Distinguished Associate Professor
Supervisor of Master's Candidates
Date of Employment:2025-12-23
School/Department:School of Basic Medical Sciences
Administrative Position:Associate Professor
Education Level:Postgraduate (Postdoctoral)
Business Address:Room 470, Xiaoqian Building, Xinglin Campus, Central South University
Sex:Male
Contact Information:wzyacademic@csu.edu.cn wzyacademic@126.com
Degree:Doctoral Degree in Medicine
Alma Mater:Tsinghua University and Capital Medical University
Discipline:Basic Medicine
Dr. Zhaoyang Wang holds a Bachelor’s degree in Preventive Medicine, a Ph.D. in Pathogenic Biology, and completed postdoctoral training in Microbiology and Infectious Diseases. He is currently a Distinguished Associate Professor and Master’s supervisor at Xiangya School of Basic Medical Sciences, Central South University. His research focuses on the infection, transmission, and pathogenic mechanisms of mosquito-borne viruses.
Dr. Wang received his Ph.D. in Medicine from Capital Medical University in July 2020 and subsequently joined Tsinghua University as a postdoctoral researcher. In December 2025, he joined the Department of Microbiology at Xiangya School of Basic Medical Sciences, Central South University. To date, he has published 14 papers as first or co-first author in leading journals including The EMBO Journal (cover article), Nature Communications, Journal of Virology (cover article), Insect Science, and PLoS Neglected Tropical Diseases. He has filed five national invention patents and has been awarded both the Outstanding Postdoctoral Fellowship and the Distinguished Postdoctoral Fellowship from the Tsinghua-Peking Joint Center for Life Sciences. He currently serves as the principal investigator of a National Natural Science Foundation of China (NSFC) Youth Project.
Dr. Wang has made pioneering contributions to the field of mosquito-host interactions and the regulatory roles of mosquito salivary proteins in arbovirus infection and transmission. His research has been highlighted in commentaries by international peers and featured in multiple academic media outlets.
Name of Research Group:Research on the Mechanisms of Vector–Mammalian Host Interactions
Name of Research Group:Research Team on Vector-Borne Viral Infection, Transmission, Pathogenic Mechanisms, and Control Stra
Description of Research Group:Vector-borne viral diseases represent a significant and shared public health challenge for China and numerous countries and regions worldwide. For the vast majority of arboviruses, neither preventive vaccines nor specific therapeutic interventions are currently available. Traditional vector control strategies have demonstrated limited efficacy, underscoring the urgent need for innovative approaches to arbovirus prevention and control. Our research group has been dedicated to investigating the infection, transmission, and pathogenic mechanisms of mosquito-borne viruses. We have established multiple arbovirus research platforms and systematically characterized the interactions between mosquito salivary proteins and mammalian hosts, as well as their impact on arbovirus infection, transmission, and pathogenicity. These efforts have resulted in a series of pioneering publications.
Building upon our previous work, the research group will pursue the following research directions: (1) Using mosquitoes and ticks as arthropod vectors, we will identify key vector salivary proteins that significantly influence arbovirus transmission and elucidate their mechanisms of action, with the goal of developing transmission-blocking strategies targeting these salivary proteins. (2) We will investigate vector salivary protein-host interactions to identify salivary proteins with anticoagulant, anti-inflammatory, and immunomodulatory properties, elucidate their mechanisms, and explore their therapeutic potential in disease treatment. (3) Employing multi-omics sequencing and high-throughput screening approaches, we will systematically identify critical host factors mediating arbovirus infection and elucidate their mechanisms, thereby providing targets for antiviral drug development. (4) We will identify key immune cells and molecules that mediate immunopathological damage induced by mosquito-borne viral infections, offering innovative therapeutic strategies for arboviral diseases. (5) Our...
